CZ63895A3 - 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use - Google Patents
5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their useInfo
- Publication number
- CZ63895A3 CZ63895A3 CZ95638A CZ63895A CZ63895A3 CZ 63895 A3 CZ63895 A3 CZ 63895A3 CZ 95638 A CZ95638 A CZ 95638A CZ 63895 A CZ63895 A CZ 63895A CZ 63895 A3 CZ63895 A3 CZ 63895A3
- Authority
- CZ
- Czechia
- Prior art keywords
- carboxylic
- naphthyridon
- ethinyl
- quinolone
- vinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/762—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/771—Organic compounds containing hetero rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Animal Husbandry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4408212A DE4408212A1 (de) | 1994-03-11 | 1994-03-11 | 5-Vinyl- und 5-Ethinyl-chinolon- und -naphthyridon-carbonsäuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CZ63895A3 true CZ63895A3 (en) | 1995-11-15 |
Family
ID=6512492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CZ95638A CZ63895A3 (en) | 1994-03-11 | 1995-03-10 | 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US5578604A (cs) |
| EP (1) | EP0671391A1 (cs) |
| JP (1) | JPH07285941A (cs) |
| KR (1) | KR950032177A (cs) |
| CN (1) | CN1111629A (cs) |
| AU (1) | AU689189B2 (cs) |
| BG (1) | BG62001B1 (cs) |
| CA (1) | CA2144231A1 (cs) |
| CO (1) | CO4340737A1 (cs) |
| CZ (1) | CZ63895A3 (cs) |
| DE (1) | DE4408212A1 (cs) |
| DZ (1) | DZ1862A1 (cs) |
| EE (1) | EE9500020A (cs) |
| FI (1) | FI951101A7 (cs) |
| HR (1) | HRP950077A2 (cs) |
| HU (1) | HUT72071A (cs) |
| IL (1) | IL112936A0 (cs) |
| LV (1) | LV11469B (cs) |
| MA (1) | MA23475A1 (cs) |
| NO (1) | NO950936L (cs) |
| NZ (1) | NZ270657A (cs) |
| PE (1) | PE33895A1 (cs) |
| PL (1) | PL307583A1 (cs) |
| RU (1) | RU95103433A (cs) |
| SK (1) | SK31695A3 (cs) |
| SV (1) | SV1995000012A (cs) |
| TN (1) | TNSN95017A1 (cs) |
| YU (1) | YU15895A (cs) |
| ZA (1) | ZA952008B (cs) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4230804A1 (de) * | 1992-09-15 | 1994-03-17 | Bayer Ag | 7-Isoindolinyl-chinolon- und -naphthyridon-Derivate |
| DE4427530A1 (de) * | 1994-08-04 | 1996-02-08 | Bayer Ag | Chinolon- und Naphthyridoncarbonsäure-Derivate |
| US6025154A (en) | 1995-06-06 | 2000-02-15 | Human Genome Sciences, Inc. | Polynucleotides encoding human G-protein chemokine receptor HDGNR10 |
| US6743594B1 (en) | 1995-06-06 | 2004-06-01 | Human Genome Sciences, Inc. | Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5) |
| DE19652219A1 (de) | 1996-12-16 | 1998-06-18 | Bayer Ag | Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen |
| US6984499B2 (en) * | 1997-10-02 | 2006-01-10 | Idexx Laboratories, Inc. | Method and apparatus for concurrently detecting pathogenic organisms and antimicrobial susceptibility |
| MXPA02005884A (es) | 1999-12-14 | 2002-10-23 | Neurosearch As | Heteroaril-diazabicicloalcanos novedosos. |
| US7175988B2 (en) | 2001-02-09 | 2007-02-13 | Human Genome Sciences, Inc. | Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| WO2002096911A1 (en) * | 2001-06-01 | 2002-12-05 | Neurosearch A/S | Novel heteroaryl-diazabicyclo-alkanes as cns-modulators |
| US7282344B2 (en) * | 2001-06-06 | 2007-10-16 | Neurosearch A/S | Cation conducting GABAA receptors and their use |
| US7393934B2 (en) | 2001-12-21 | 2008-07-01 | Human Genome Sciences, Inc. | Human G-protein chemokine receptor (CCR5) HDGNR10 |
| CN100410249C (zh) | 2003-09-10 | 2008-08-13 | 杏林制药株式会社 | 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物 |
| WO2005105841A2 (en) | 2004-03-12 | 2005-11-10 | Human Genome Sciences, Inc. | Human g-protein chemokine receptor (ccr5) hdgnr10 |
| CA2688008A1 (en) | 2007-05-24 | 2008-11-27 | Kyorin Pharmaceutical Co., Ltd. | Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position |
| CN103724262B (zh) * | 2013-12-10 | 2016-05-18 | 广东省第二人民医院 | 一种氟喹诺酮银化合物及其制备方法和用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5563138A (en) * | 1987-04-16 | 1996-10-08 | Otsuka Pharmaceutical Company, Limited | Benzoheterocyclic compounds |
| EP0319906A3 (en) * | 1987-12-11 | 1990-05-02 | Dainippon Pharmaceutical Co., Ltd. | Novel quinoline derivatives, processes for preparation thereof and antibacterial agent containing them |
| US4920120A (en) * | 1988-01-25 | 1990-04-24 | Warner-Lambert Company | Antibacterial agents |
| AU5123690A (en) * | 1989-03-13 | 1990-09-13 | Bristol-Myers Squibb Company | 5-substituted-1,4-dihydro-4-oxo-nephthyridine-3-carboxylate antibacterial agents |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| US5252734A (en) * | 1989-04-03 | 1993-10-12 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| US5140033A (en) * | 1989-04-03 | 1992-08-18 | Bayer Aktiengesellschaft | Antibacterial 5-alkylquinolonecarboxylic acids |
| US5696132A (en) * | 1991-05-28 | 1997-12-09 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives |
-
1994
- 1994-03-11 DE DE4408212A patent/DE4408212A1/de not_active Withdrawn
-
1995
- 1995-02-20 HR HRP4408212.6A patent/HRP950077A2/hr not_active Application Discontinuation
- 1995-02-27 EP EP95102762A patent/EP0671391A1/de not_active Withdrawn
- 1995-03-03 US US08/398,328 patent/US5578604A/en not_active Expired - Fee Related
- 1995-03-06 CO CO95008716A patent/CO4340737A1/es unknown
- 1995-03-06 DZ DZ950026A patent/DZ1862A1/fr active
- 1995-03-06 AU AU13649/95A patent/AU689189B2/en not_active Ceased
- 1995-03-06 PE PE1995263451A patent/PE33895A1/es not_active Application Discontinuation
- 1995-03-08 EE EE9500020A patent/EE9500020A/xx unknown
- 1995-03-08 IL IL11293695A patent/IL112936A0/xx unknown
- 1995-03-08 NZ NZ270657A patent/NZ270657A/en unknown
- 1995-03-08 YU YU15895A patent/YU15895A/sh unknown
- 1995-03-08 PL PL95307583A patent/PL307583A1/xx unknown
- 1995-03-08 CA CA002144231A patent/CA2144231A1/en not_active Abandoned
- 1995-03-09 BG BG99490A patent/BG62001B1/bg unknown
- 1995-03-09 TN TNTNSN95017A patent/TNSN95017A1/fr unknown
- 1995-03-09 JP JP7077134A patent/JPH07285941A/ja active Pending
- 1995-03-09 FI FI951101A patent/FI951101A7/fi unknown
- 1995-03-10 HU HU9500728A patent/HUT72071A/hu unknown
- 1995-03-10 RU RU95103433/04A patent/RU95103433A/ru unknown
- 1995-03-10 CN CN95102213A patent/CN1111629A/zh active Pending
- 1995-03-10 CZ CZ95638A patent/CZ63895A3/cs unknown
- 1995-03-10 KR KR1019950004888A patent/KR950032177A/ko not_active Withdrawn
- 1995-03-10 MA MA23803A patent/MA23475A1/fr unknown
- 1995-03-10 ZA ZA952008A patent/ZA952008B/xx unknown
- 1995-03-10 LV LVP-95-48A patent/LV11469B/lv unknown
- 1995-03-10 SV SV1995000012A patent/SV1995000012A/es unknown
- 1995-03-10 SK SK316-95A patent/SK31695A3/sk unknown
- 1995-03-10 NO NO950936A patent/NO950936L/no unknown
-
1996
- 1996-05-03 US US08/642,662 patent/US5659038A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9901556A0 (en) | Sulpponamide derivatives process for their preparation and their use as medicaments | |
| IL129315A0 (en) | Oxadiazoles process for their preparation and their use as medicaments | |
| ZA953501B (en) | Erythromycin derivatives their preparation process and their use as medicaments | |
| ZA952059B (en) | Erythromycin derivatives their preparation process and their use as medicaments | |
| HUP0100280A3 (en) | Pyrrolo-, thieno-, furano- and pyrazolo- [3,4d]-pyridazinones, process for their preparation and pharmaceutical compositions containing them | |
| CZ161599A3 (cs) | N-substituované 2-kyanopyrrolidiny, způsob jejich přípravy a jejich použití jako léčiv | |
| HUP0102556A3 (en) | Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds | |
| IL128118A0 (en) | Modified amino acids medicaments containing these compounds and processes for their preparation | |
| HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
| CZ63895A3 (en) | 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use | |
| ZA9557B (en) | Optionally substituted phenylimidazolidines their preparation process and intermediates their use as medicaments and the pharmaceutical compositions containing them | |
| ZA984266B (en) | Pharmaceutical composition and process of preparation | |
| HUP9901434A3 (en) | Substituted benzylamines and their use for the preparation of medicaments for treating depression | |
| ZA97277B (en) | Novel benzoylguanidine derivatives processes for preparing them and their use in the preparation of pharmaceutical compositions | |
| IL124768A0 (en) | Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents | |
| CZ92295A3 (en) | Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof | |
| ZA988285B (en) | 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles process for their preparation and their use for medicaments | |
| AU3011095A (en) | 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments | |
| HUP9600665A3 (en) | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation | |
| IL121407A0 (en) | Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them | |
| HRP960063B1 (en) | Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them | |
| ZA9711101B (en) | Derivatives of erythromycin their preparation process and their use as medicaments | |
| IL130831A (en) | Imino-aza-anthrayclinone derivatives, process for their preparation and pharmaceutical compositions comprising them for the treatment of amyloidosis | |
| IL117179A (en) | Substituted benzenesulfonylureas and-thioureas processes for their preparation and use thereof in the production of medicaments and pharmaceutical compositions containing them | |
| ZA9711324B (en) | Steroids substituted in position 11 their preparation process their use as medicaments and the pharmaceutical compounds containing them |